SABS - SAB Biotherapeutics, Inc.
3.52
-0.280 -7.955%
Share volume: 555,769
Last Updated: 04-24-2026
Pharmaceutical Products/Biological Products, Except Diagnostic Substances:
0.21%
PREVIOUS CLOSE
CHG
CHG%
$3.80
-0.28
-0.07%
Summary score
37%
Profitability
36%
Dept financing
24%
Liquidity
58%
Performance
35%
Sector
Manufacturing
Industry
Pharmaceutical Products/Biological Products, Except Diagnostic Substances
Long-term ratios 31-Dec-2021 - 31-Dec-2025
The data are presented for the financials results of the quarters of the last 4 years.
Return on equity
-22.98%
Return on assets
-12.53%
Return on sales
-2127.9%
Return on invested capital
-50.59%
Total debt ratio
33.64%
Debt ratio change over timeo
-1.19%
Current Ratio
3.6%
Quick Ratio
2.2%
Cash Position Ratio
1.7%
Short-term ratios 31-Dec-2024 - 31-Dec-2025
The data are presented for the financials results of the quarters of the last year.
Return on equity
0%
Return on assets
0.23%
Return on sales
0%
Return on invested capital
0%
Total debt ratio
22.06%
Debt ratio change over timeo
0%
Current Ratio
7.21%
Quick Ratio
0%
Cash Position Ratio
1.43%
Last quarter ratios 31-Dec-2025
The data are presented for the financials results of the last quarter.
Return on equity
0%
Return on assets
-10.13%
Return on sales
0%
Return on invested capital
0%
Total debt ratio
12.33%
Debt ratio change over time
0%
Current Ratio
9.46%
Quick Ratio
0%
Cash Position Ratio
0.98%
Performance ratios (change over 4 years) 31-Dec-2021 - 31-Dec-2025
The data are presented for the change financials results of the quarter of the last 4 years.
Return on equity
-65.48%
Return on assets
-82.54%
Return on sales
5473.56%
Return on invested capital
-20.56%
Total debt ratio
-119.27%
Debt ratio change over time
-1.19%
Current Ratio
-3.87%
Quick Ratio
-2.12%
Cash Position Ratio
-3.27%
Compare in sector
The following table compares the individual analyzes for the other top 3 stocks within the same industry.
| Long-term ratios | SABS | AMGN | GILD | BIIB |
|---|---|---|---|---|
| Return on equity | -22.98% | 0% | 5.97% | 8.91% |
| Return on assets | -12.53% | 2.97% | 3.34% | 2.04% |
| Return on sales | -2127.9% | 27.71% | 27.82% | 21.49% |
| Return on invested capital | -50.59% | 0% | 3.51% | 10.25% |
| Profitability | 0% | 47% | 75% | 85% |
| Total debt ratio | 33.64% | 93.27% | 65.75% | 43.64% |
| Debt ratio change over time | -1.19% | 14.34% | 187.33% | 9.75% |
| Dept financing | 9% | 27% | 43% | 13% |
| Current Ratio | 7.21% | 1.22% | 1.42% | 2.33% |
| Quick Ratio | 0% | 0.94% | 1.27% | 1.72% |
| Cash Position Ratio | 1.43% | 0.39% | 0.58% | 0.86% |
| Liquididy | 75% | 38% | 31% | 45% |
| Short-term ratios | SABS | AMGN | GILD | BIIB |
|---|---|---|---|---|
| Return on equity | 0% | 0% | 0% | 0% |
| Return on assets | 0.23% | 3.27% | 4.7% | 1.36% |
| Return on sales | 0% | 24.35% | 34.09% | 15.11% |
| Return on invested capital | 0% | 0% | 0% | 0% |
| Profitability | 51% | 35% | 50% | 18% |
| Total debt ratio | 22.06% | 91.09% | 63.87% | 38.21% |
| Debt ratio change over time | 0% | 0% | 0% | 0% |
| Dept financing | 31% | 25% | 18% | 10% |
| Current Ratio | 7.21% | 1.22% | 1.42% | 2.33% |
| Quick Ratio | 0% | 0.94% | 1.27% | 1.72% |
| Cash Position Ratio | 1.43% | 0.39% | 0.58% | 0.86% |
| Liquididy | 50% | 25% | 34% | 48% |